B Rizovski
Overview
Explore the profile of B Rizovski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmidt W, Kalipciyan M, Dornstauder E, Rizovski B, Sedivy R, Steger G, et al.
Int J Clin Pharmacol Ther
. 2003 Dec;
41(12):624-5.
PMID: 14692722
No abstract available.
2.
Mader R, Schrolnberger C, Rizovski B, Brunner M, Wenzel C, Locker G, et al.
Br J Cancer
. 2003 Mar;
88(5):782-7.
PMID: 12618890
Capecitabine is an oral prodrug of 5-fluorouracil (FU). Since FU concentrations achieved in malignant lesions are an important determinant of efficacy, we investigated the intratumoral transcapillary transfer of capecitabine and...
3.
Mader R, Schrolnberger C, Rizovski B, Brunner M, Wenzel C, Locker G, et al.
Int J Clin Pharmacol Ther
. 2002 Dec;
40(12):571-2.
PMID: 12503818
No abstract available.
4.
Mader R, Rizovski B, Steger G
J Chromatogr B Analyt Technol Biomed Life Sci
. 2002 May;
769(2):357-61.
PMID: 11996502
The application of coupled-column liquid chromatographic analysis to pharmacokinetic studies eliminates the need for sample clean-up from plasma. Considering lipophilic antineoplastic agents, we tested this approach to analyze paclitaxel under...
5.
Joukhadar C, Klein N, Mader R, Schrolnberger C, Rizovski B, Heere-Ress E, et al.
Cancer
. 2001 Oct;
92(8):2190-6.
PMID: 11596037
Background: Dacarbazine has been on the market for approximately 3 decades but remains the most effective single agent available for the therapy of metastatic malignant melanoma (MMM). Most MMMs, however,...
6.
Mader R, Schmidt W, Sedivy R, Rizovski B, Braun J, Kalipciyan M, et al.
J Lab Clin Med
. 2001 Jun;
137(6):422-8.
PMID: 11385363
Using reverse transcriptase-polymerase chain reaction (RT-PCR), we have recently described a bona fide deletion within the coding sequence of the large subunit of ribonucleotide reductase (R1) mRNA in colon cancer....
7.
Pilger A, Kohler I, Stettner H, Mader R, Rizovski B, Terkola R, et al.
Int Arch Occup Environ Health
. 2000 Nov;
73(7):442-8.
PMID: 11057412
Objectives: Many antineoplastic drugs were found to have carcinogenic, mutagenic and teratogenic potential. The aim of this study was to carry out cytogenetic and internal dose monitoring of hospital pharmacy...
8.
Locker G, Mader R, Rizovski B, Knapp S, Domanovits H, Muellner M, et al.
J Pharmacol Exp Ther
. 1999 Jun;
290(1):43-50.
PMID: 10381758
Opioids are well known to cause cardiovascular depression. The aim of the present investigation was to determine whether an interaction of opioid derivatives with catecholamines might be involved in these...
9.
Mader R, Brunner M, Rizovski B, Mensik C, Steger G, Eichler H, et al.
Electrophoresis
. 1998 Dec;
19(16-17):2981-5.
PMID: 9870399
Microdialysis (MD) is an innovative clinical technique for measuring interstitial tissue pharmacokinetics and plasma-to-tissue transfer rates of drugs in humans. However, microdialysis requires the availability of specialized analytical techniques. Capillary...
10.
Mader R, Sieder A, Braun J, Rizovski B, Kalipciyan M, Mueller M, et al.
Biochem Pharmacol
. 1998 Jan;
54(11):1233-42.
PMID: 9416974
Cellular resistance to 5-fluorouracil (5-FU) is not completely understood. Since 5-FU shares the pyrimidine pathway with the physiological pyrimidines, we investigated the relationship between fluoropyrimidine metabolism, nucleic acid uptake and...